UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Journal of clinical oncology, 2011-04, Vol.29 (11), p.1465-1471

2011

Volltextzugriff (PDF)

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

The New England journal of medicine, 2005-06, Vol.352 (26), p.2696-2704

2005

Volltextzugriff (PDF)

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

The New England journal of medicine, 2000-09, Vol.343 (13), p.905-914

2000

Volltextzugriff (PDF)

American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3408-3419

2004

Volltextzugriff (PDF)

Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group

Journal of clinical oncology, 2004-08, Vol.22 (16), p.3395-3407

2004

Volltextzugriff (PDF)

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2282-2292

2001

Volltextzugriff (PDF)

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Journal of clinical oncology, 2007-01, Vol.25 (1), p.102-109

2007

Volltextzugriff (PDF)

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

Clinical & experimental metastasis, 2012-02, Vol.29 (2), p.123-132

2012

Volltextzugriff (PDF)

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

BMC cancer, 2003-10, Vol.3 (1), p.26-26, Article 26

2003

Volltextzugriff (PDF)

Pulmonary hypertension in extremely low birth weight infants: characteristics and outcomes

World journal of pediatrics : WJP, 2014-02, Vol.10 (1), p.46-52

2014

Volltextzugriff (PDF)

The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants

World journal of pediatrics : WJP, 2014-08, Vol.10 (3), p.204-210

2014

Volltextzugriff (PDF)

Role of fine-needle aspiration in the surgical management of pancreatic neuroendocrine tumors: utility and limitations in light of the new World Health Organization classification

Archives of pathology & laboratory medicine (1976), 2014-07, Vol.138 (7), p.896-902

2014

Volltextzugriff (PDF)

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3733-3740

2015

Volltextzugriff (PDF)

Hematological toxicity with adjuvant FOLFOX in colon cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15062-e15062

2016

Volltextzugriff (PDF)

Resistance of Colorectal Cancer Cells to 5-FUdR and 5-FU Caused by Mycoplasma Infection

Anticancer research, 2008-07, Vol.28 (4B), p.2175-2180

2008

Volltextzugriff (PDF)

EGFR expression variance in paired colorectal cancer primary and metastatic tumors

Cancer biology & therapy, 2010-09, Vol.10 (5), p.416-421

2010

Volltextzugriff (PDF)

Survival outcomes associated with chemotherapy-induced neutropenia in the adjuvant treatment of colorectal cancer with FOLFOX

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.81-81

2022

Volltextzugriff (PDF)

A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer

Investigational new drugs, 2005-01, Vol.23 (2), p.165-170

2005

Volltextzugriff (PDF)

Retrospective review of FOLFIRI with or without bevacizumab (bev) for patients (pts) with metastatic colorectal cancer (mCRC): Reviewing a single-center standard clinical practice

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.434-434

2014

Volltextzugriff (PDF)

Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group

Annals of surgical oncology, 2015-08, Vol.22 (8), p.2685-2699

2015

Volltextzugriff (PDF)

P-0164 Online System For Decentralized Review of Digital Medical Images And its Use in Multicenter Clinical Trials

Annals of oncology, 2012-06, Vol.23, p.iv77

2012

Volltextzugriff (PDF)

Nuclear Expression of Thymidylate Synthase in Colorectal Cancer Cell Lines and Clinical Samples

The journal of histochemistry and cytochemistry, 2006-01, Vol.54 (1), p.19-29

2006

Volltextzugriff (PDF)

Respiratory management of extremely low birth weight infants: survey of neonatal specialists

World journal of pediatrics : WJP, 2016-08, Vol.12 (3), p.314-319

2016

Volltextzugriff (PDF)

Chemotherapy-induced neutropenia with FOLFOX in the adjuvant treatment of colorectal cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.38-38

2020

Volltextzugriff (PDF)

A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada

PharmacoEconomics, 2003-01, Vol.21 (14), p.1039-1051

2003

Volltextzugriff (PDF)

1 – 25 von 254

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(219)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(243)
Französisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Life Sciences & Biomedicine
(123)
Humans
(100)
Female
(58)
Oncology
(58)
Male
(53)
Middle Aged
(51)
Aged
(47)
Biological And Medical Sciences
(43)
Adult
(42)
Medical Sciences
(40)
Life Sciences
(32)
Physical Sciences
(31)
Chemotherapy
(30)
Technology
(28)
Antineoplastic Agents
(26)
Pharmacology. Drug Treatments
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Engineering Sciences
(21)
Chemistry
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

Pulmonary hypertension in extremely low birth weight infants: characteristics and outcomes

The role of surfactant and non-invasive mechanical ventilation in early management of respiratory distress syndrome in premature infants

Role of fine-needle aspiration in the surgical management of pancreatic neuroendocrine tumors: utility and limitations in light of the new World Health Organization classification

Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial

Hematological toxicity with adjuvant FOLFOX in colon cancer

Resistance of Colorectal Cancer Cells to 5-FUdR and 5-FU Caused by Mycoplasma Infection

EGFR expression variance in paired colorectal cancer primary and metastatic tumors

Survival outcomes associated with chemotherapy-induced neutropenia in the adjuvant treatment of colorectal cancer with FOLFOX

A phase II trial of ZD1839 (Iressa) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer

Retrospective review of FOLFIRI with or without bevacizumab (bev) for patients (pts) with metastatic colorectal cancer (mCRC): Reviewing a single-center standard clinical practice

Consensus Recommendations for the Diagnosis and Management of Pancreatic Neuroendocrine Tumors: Guidelines from a Canadian National Expert Group

P-0164 Online System For Decentralized Review of Digital Medical Images And its Use in Multicenter Clinical Trials

Nuclear Expression of Thymidylate Synthase in Colorectal Cancer Cell Lines and Clinical Samples

Respiratory management of extremely low birth weight infants: survey of neonatal specialists

Chemotherapy-induced neutropenia with FOLFOX in the adjuvant treatment of colorectal cancer

A cost comparison of oral tegafur plus uracil/folinic acid and parenteral fluorouracil for colorectal cancer in Canada

Suchergebnisse filtern